To determine potential mediators of NOX2-induced Egr-1 expression and ultimately TKI-resistance, we utilized ingenuity pathway analysis to uncover genes that were coordinately regulated in TKI-resistant CML [39] and BC-LSCs [48] (Figure 7A). This evidence concerns the gene EGR1 and breast cancer.